Oct. 12 (Wed.) ,2016 15:00-16:00

Annex Hall
F201

Simultaneous Interpretation

The time of this session has changed from the original schedule.

Chugai Pharmaceutical

Open Innovation and Drug Discovery in Chugai

In the current circumstances that the social requirement for the value of new drugs is markedly increasing, Chugai Pharmaceutical has tied to develop and strengthen Chugai’s own drug discovery technologies that can accelerate the speed of R&D process against a huge variety of drug target molecules and can add a clear medical value in order to create first-in-class or best-in-class therapeutics. However, the excellence of technologies is not enough for creating innovative drugs. It requires fusion of excellent drug seeds with such technologies. Here, I’d like to present Chugai’s activities for increasing the chances to meet excellent drug seeds that academia possesses.

Open Innovation and Drug Discovery in Chugai

Kunihiro Hattori

Associate Vice President Research Division, Fellow, Chugai Pharmaceutical

Close Window